Mark Carey

9.8k citations

75 papers · 5.1k indexed · 2 hit papers · h-index 32

Impact in

Reproductive Medicine top 0.5%
- Ovarian cancer diagnosis and treatment
Cancer Research top 1%
- Cancer, Hypoxia, and Metabolism
- Cancer, Lipids, and Metabolism
- Cancer Genomics and Diagnostics

Papers in ⓘ

Reproductive Medicine 35
- Ovarian cancer diagnosis and treatment 33
- Endometriosis Research and Treatment 6
Molecular Biology 33
- Chromatin Remodeling and Cancer 6

Co-authors: Gordon B. Mills (22 shared papers)Bryan T. Hennessy (25 shared papers)Kristin M. Nieman (1 shared paper)Gökhan S. Hotamışlıgil (1 shared paper)Rebecca Buell‐Gutbrod (1 shared paper)Marcus E. Peter (1 shared paper)Katja Gwin (1 shared paper)Hilary A. Kenny (1 shared paper)
Journals: Gynecologic Oncology (11 papers)International Journal of Gynecological Cancer (7 papers)Clinical Cancer Research (5 papers)Journal of Clinical Oncology (4 papers)Cancer Research (3 papers)
Partner nations: Canada United States Ireland

In The Last Decade

Mark Carey

73 papers receiving 5.0k citations

Hit Papers

align trajectories log scale

Patterns of genomic loss of heterozygosity predict homologous recombination repair defects in epithelial ovarian cancer 2012 · 494 citations

Peers

Countries citing papers authored by Mark Carey

Since Specialization

Citations

This map shows the geographic impact of Mark Carey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Carey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Carey more than expected).

Fields of papers citing papers by Mark Carey

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Carey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Carey. The network helps show where Mark Carey may publish in the future.

Co-authors

The 25 scholars most cited alongside Mark Carey, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mark Carey Line = papers co-authored together Mark Carey links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 75 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth Nature Medicine ·Kristin M. Nieman, Hilary A. Kenny, Carla Penicka, András Ladányi, Rebecca Buell‐Gutbrod, Marion Zillhardt, Iris L. Romero, Mark Carey, Gordon B. Mills, Gökhan S. Hotamışlıgil, S. Diane Yamada, Marcus E. Peter, Katja Gwin, Ernst Lengyel Hit paper breakdown →	2011	1707
2	Patterns of genomic loss of heterozygosity predict homologous recombination repair defects in epithelial ovarian cancer British Journal of Cancer ·Victor Abkevich, Kirsten M. Timms, Bryan T. Hennessy, Jennifer Potter, Mark Carey, Lisa Meyer, Karen Smith‐McCune, Russell Broaddus, K.H. Lu, J Chen, Thuan Van Tran, Deniece R. Williams, Diana Iliev, Srikanth Jammulapati, Liesel M. FitzGerald, Thomas C. Krivak, Julie A. DeLoia, Alexander Gutin, Gordon B. Mills, J. S. Lanchbury Hit paper breakdown →	2012	494
3	Somatic Mutations in BRCA1 and BRCA2 Could Expand the Number of Patients That Benefit From Poly (ADP Ribose) Polymerase Inhibitors in Ovarian Cancer Journal of Clinical Oncology ·Bryan T. Hennessy, Kirsten M. Timms, Mark Carey, Alexander Gutin, Larissa A. Meyer, Darl D. Flake, Victor Abkevich, Jennifer Potter, Dmitry Pruss, Pat Glenn, Yang Li, Jie Li, Ana M. González-Angulo, Karen McCune, Maurie Markman, Russell R. Broaddus, Jerry S. Lanchbury, Karen H. Lu, Gordon B. Mills	2010	289
4	A brief mindfulness-based cognitive behavioral intervention improves sexual functioning versus wait-list control in women treated for gynecologic cancer Gynecologic Oncology ·Lori A. Brotto, Yvonne Erskine, Mark Carey, Tom Ehlen, Sarah Finlayson, M. Heywood, Janice S. Kwon, Jessica N. McAlpine, Gavin Stuart, Sydney Thomson, Dianne Miller	2012	191
5	Clear cell carcinoma of the ovary: A report from the first Ovarian Clear Cell Symposium, June 24th, 2010 Gynecologic Oncology ·Michael S. Anglesio, Mark Carey, Martin Köbel, Helen Mackay, David G. Huntsman	2011	185
6	Androgen Receptor Levels and Association with PIK3CA Mutations and Prognosis in Breast Cancer Clinical Cancer Research ·Ana M. González-Angulo, Katherine Stemke‐Hale, Shana L. Palla, Mark Carey, Roshan Agarwal, Funda Meric-Berstam, Tiffany A. Traina, Clifford A. Hudis, Gabriel N. Hortobágyi, William L. Gerald, Gordon B. Mills, Bryan T. Hennessy	2009	173
7	Good Outcome Associated with a Standardized Treatment Protocol Using Selective Postoperative Radiation in Patients with Clinical Stage I Adenocarcinoma of the Endometrium Gynecologic Oncology ·Mark Carey, G. OʼConnell, Curtis R. Johanson, Michael Goodyear, Kelley J. Murphy, Dean Daya, A. Schepansky, A Péloquin, Brenda J. Lumsden	1995	124
8	BRCA1/2 mutation analysis in 41 ovarian cell lines reveals only one functionally deleterious BRCA1 mutation Molecular Oncology ·Britta Stordal, Kirsten M. Timms, Angela M. Farrelly, David Gallagher, Steven Busschots, Mickaël Renaud, Julien Thery, Deborah Williams, Jennifer Potter, Thanh V. Tran, Greg Korpanty, Mattia Cremona, Mark Carey, Jie Li, Yang Li, Ozlem Aslan, John O’Leary, Gordon B. Mills, Bryan T. Hennessy	2013	116
9	Integrative Analysis of Cyclin Protein Levels Identifies Cyclin B1 as a Classifier and Predictor of Outcomes in Breast Cancer Clinical Cancer Research ·Roshan Agarwal, Ana-Maria Gonzalez-Angulo, Simen Myhre, Mark Carey, Ju‐Seog Lee, Jens Overgaard, Jan Alsner, Katherine Stemke‐Hale, Aňa Lluch, Richard M. Neve, Wen Lin Kuo, Thérese Sørlie, Ayşegül A. Şahin, Vicente Valero, Khandan Keyomarsi, Joe W. Gray, Anne‐Lise Børresen‐Dale, Gordon B. Mills, Bryan T. Hennessy	2009	111
10	Targeting the Epidermal Growth Factor Receptor in Epithelial Ovarian Cancer: Current Knowledge and Future Challenges Journal of Oncology ·Doris R. Siwak, Mark Carey, Bryan T. Hennessy, Catherine T. Nguyen, Mollianne J. McGahren Murray, Laura K. Nolden, Gordon B. Mills	2009	111
11	Pharmacodynamic Markers of Perifosine Efficacy Clinical Cancer Research ·Bryan T. Hennessy, Yiling Lu, Enrique Poradosu, Qianghua Yu, Shuangxing Yu, Hassan Hall, Mark Carey, Murali K. Ravoori, Ana M. González-Angulo, Robert Birch, I. Craig Henderson, Vikas Kundra, Gordon B. Mills	2007	94
12	Subtype‐specific mutation of PPP2R1A in endometrial and ovarian carcinomas The Journal of Pathology ·Melissa K. McConechy, Michael S. Anglesio, Steve E. Kalloger, Winnie Yang, Janine Senz, Christine Chow, Alireza Heravi‐Moussavi, Gregg B. Morin, Anne‐Marie Mes‐Masson, (unknown), Mark Carey, Jessica N. McAlpine, Janice S. Kwon, Leah Prentice, Niki Boyd, Sohrab P. Shah, C. Blake Gilks, David G. Huntsman	2011	86
13	Endometriosis and endometriosis-associated cancers: new insights into the molecular mechanisms of ovarian cancer development ecancermedicalscience ·Amy Dawson, Marta Llauradó Fernández, Michael S. Anglesio, Paul J. Yong, Mark Carey	2018	78
14	The Changing Face of Trauma Management and Its Impact on Surgical Resident Training The Journal of Trauma: Injury, Infection, and Critical Care ·Patrick P. Bulinski, Ben L. Bachulis, Douglas F. Naylor, David Kam, Mark Carey, Richard E. Dean	2003	74
15	Integrative Analysis of Proteomic Signatures, Mutations, and Drug Responsiveness in the NCI 60 Cancer Cell Line Set Molecular Cancer Therapeutics ·Eun Sung Park, Rosalia Rabinovsky, Mark Carey, Bryan T. Hennessy, Roshan Agarwal, Wenbin Liu, Zhenlin Ju, Wanleng Deng, Yiling Lu, Hyun Goo Woo, Sang-Bae Kim, Jae‐Ho Cheong, Levi A. Garraway, John N. Weinstein, Gordon B. Mills, Ju‐Seog Lee, Michael A. Davies	2010	71
16	Rab25 increases cellular ATP and glycogen stores protecting cancer cells from bioenergetic stress EMBO Molecular Medicine ·Kwai Wa Cheng, Roshan Agarwal, Shreya Mitra, Ju‐Seog Lee, Mark Carey, Joe W. Gray, Gordon B. Mills	2012	66
17	A functional proteogenomic analysis of endometrioid and clear cell carcinomas using reverse phase protein array and mutation analysis: protein expression is histotype-specific and loss of ARID1A/BAF250a is associated with AKT phosphorylation BMC Cancer ·Kimberly C. Wiegand, Bryan T. Hennessy, Samuel Leung, Yemin Wang, Zhenlin Ju, Mollianne J. McGahren, Steve E. Kalloger, Sarah Finlayson, Katherine Stemke‐Hale, Yiling Lu, Fan Zhang, Michael S. Anglesio, C. Blake Gilks, Gordon B. Mills, David G. Huntsman, Mark Carey	2014	65
18	Markers of low level arsenic exposure for evaluating human cancer risks in a US population. PubMed ·Margaret R. Karagas, X. Chris Le, Stephen Morris, Joel D. Blum, Xiufen Lu, Vicky Spate, Mark Carey, Virginia Stannard, Bjoern Klaue, Tor D. Tosteson	2001	59
19	Influence of DNA copy number and mRNA levels on the expression of breast cancer related proteins Molecular Oncology ·Simen Myhre, Ole Christian Lingjærde, Bryan T. Hennessy, Miriam R. R. Aure, Mark Carey, Jan Alsner, Trine Tramm, Jens Overgaard, Gordon B. Mills, Anne‐Lise Børresen‐Dale, Thérese Sørlie	2013	55
20	Proteomic Profiling Identifies Pathways Dysregulated in Non-small Cell Lung Cancer and an Inverse Association of AMPK and Adhesion Pathways with Recurrence Journal of Thoracic Oncology ·Meera Nanjundan, Lauren A. Byers, Mark Carey, Doris R. Siwak, Maria Gabriela Raso, Lixia Diao, Jing Wang, Kevin R. Coombes, Jack A. Roth, Gordon B. Mills, Ignacio I. Wistuba, John D. Minna, John V. Heymach	2010	50

About Mark Carey

Mark Carey is a scholar working on Reproductive Medicine, Molecular Biology, Oncology, Cancer Research and Obstetrics and Gynecology, having authored 75 papers that have together received 5.1k indexed citations. Recurring topics across this work include Ovarian cancer diagnosis and treatment (33 papers), Endometrial and Cervical Cancer Treatments (11 papers), Cancer Genomics and Diagnostics (11 papers), Cancer Mechanisms and Therapy (8 papers), PARP inhibition in cancer therapy (7 papers), BRCA gene mutations in cancer (6 papers), Chromatin Remodeling and Cancer (6 papers) and Endometriosis Research and Treatment (6 papers). The work is most often cited by research in Reproductive Medicine (1.3k citations), Cancer Research (1.6k citations), Obstetrics and Gynecology (558 citations), Oncology (1.8k citations) and Molecular Biology (2.5k citations). Mark Carey has collaborated with scholars based in Canada, United States and Ireland. Frequent co-authors include Gordon B. Mills, Bryan T. Hennessy, Kristin M. Nieman, Gökhan S. Hotamışlıgil, Rebecca Buell‐Gutbrod, Marcus E. Peter, Katja Gwin, Hilary A. Kenny, Iris L. Romero and András Ladányi. Their work appears in journals such as Gynecologic Oncology, International Journal of Gynecological Cancer, Clinical Cancer Research, Journal of Clinical Oncology and Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact